However, despite promising perspectives for personalized therapy, breast cancer management seems to remain caught between two worlds: the old world of familiar groupings defined by estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status and a new world of seemingly endless and complex ways to classify breast cancers [3]. The gene discussed is ESR1; the disease is breast cancer.